ebolaviru
ebov
highli
virul
pathogen
capabl
caus
sever
hemorrhag
fever
lethal
ebov
glycoprotein
gp
viral
express
protein
virion
surfac
critic
attach
host
cell
catalysi
membran
fusion
henc
ebov
gp
critic
compon
vaccin
well
target
neutral
antibodi
inhibitor
attach
fusion
crystal
structur
zair
ebolaviru
gp
trimer
prefus
conform
gp
plu
gp
complex
neutral
antibodi
fragment
deriv
human
survivor
kikwit
outbreak
recent
determin
first
nearcomplet
structur
filoviru
glycoprotein
overal
molecular
architectur
zair
ebolaviru
gp
role
viral
entri
membran
fusion
discuss
articl
symptom
resembl
sever
septic
shock
current
approv
antivir
therapeut
although
live
attenu
zebov
glycoprotein
gp
pseudotyp
vesicular
stomat
indiana
viru
vaccin
shown
promis
use
case
laboratori
needlestick
accid
hamburg
germani
frequent
reemerg
ebov
africa
includ
recent
emerg
new
speci
potenti
introduct
viru
nonendem
countri
concern
potenti
misus
viru
lack
vaccin
treatment
make
ebov
consider
public
health
concern
ebov
genom
contain
seven
gene
np
gp
l
howev
seven
protein
produc
owe
cotranscript
edit
posttransl
process
gp
gene
gene
product
figur
primari
open
read
frame
well
conserv
among
ebolavir
gp
gene
encod
nonstructur
protein
term
secret
gp
sgp
posttransl
proteolyt
cleavag
presgp
furin
yield
matur
sgp
heavili
oglycosyl
small
nonstructur
secret
protein
term
monom
sgp
join
parallel
orient
two
disulfid
bond
pair
residu
form
kda
homodim
secret
matur
sgp
six
predict
nlink
glycosyl
site
five
site
use
consist
sgp
also
contain
rare
modif
carbon
atom
attach
group
yet
known
whether
sgp
play
import
role
pathogenesi
marburgviru
marv
produc
ortholog
protein
yet
induc
indistinguish
diseas
nonhuman
primat
human
natur
infect
ebov
howev
larg
amount
sgp
detect
blood
infect
patient
antibodi
survivor
sera
appear
preferenti
recogn
sgp
gp
henc
sgp
could
play
role
evas
humor
immun
respons
absorb
elicit
antibodi
sgp
also
suggest
play
antiinflammatori
role
induc
recoveri
endotheli
barrier
function
gp
gene
encod
seven
consecut
adenosin
nucleotid
within
predict
hairpin
loop
l
polymeras
stutter
site
transcript
result
insert
addit
adenosin
nucleotid
transcript
insert
caus
frameshift
code
rna
dictat
product
amino
acid
rebov
type
transmembran
gp
term
pregp
result
frameshift
gp
sgp
ident
amino
acid
nterminu
distinct
ctermini
differ
ctermini
lead
uniqu
pattern
disulfid
bond
differ
structur
sgp
dimer
final
gp
trimer
initi
ebov
pregp
cleav
furin
multibas
motif
two
subunit
gp
gp
remain
associ
disulfid
linkag
gp
gp
heterodim
gp
gp
assembl
trimer
surfac
nascent
virion
enzym
tace
releas
virionattach
gp
cleavag
site
proxim
transmembran
anchor
virionattach
gp
critic
ebov
life
cycl
sole
respons
attach
fusion
entri
target
cell
moreov
gp
respons
critic
pathogen
differ
among
viral
speci
adenovir
express
zebov
gp
caus
endotheli
cell
damag
human
monkey
vessel
explant
rebov
cytotox
monkey
vessel
zebov
rebov
also
differ
suscept
furin
cleavag
amino
acid
sequenc
tace
cleavag
site
moreov
report
vitro
vivo
express
studi
cell
overexpress
gp
caus
cytotox
downregul
number
cellular
surfac
protein
includ
sever
involv
cellular
adhes
integrin
integrin
v
integrin
immun
surveil
mhc
class
cytotox
caus
gp
depend
highli
nand
olink
glycosyl
domain
term
mucinlik
domain
howev
role
gp
cytotox
ebov
pathogenesi
remain
poorli
defin
constitut
express
ebov
gp
moder
level
caus
cell
round
cytotox
addit
extra
adenosin
lead
product
gp
delet
one
addit
two
adenosin
transcript
stutter
lead
express
third
product
nonstructur
small
sgp
term
ssgp
ssgp
share
first
ntermin
residu
sgp
gp
differ
cterminu
thought
monomer
unclear
role
ssgp
play
ebov
pathogenesi
recent
publish
crystal
structur
zebov
gp
trimer
prefus
form
complex
neutral
antibodi
identifi
human
survivor
gp
molecul
reveal
multisubunit
chaliceshap
trimer
thick
coat
oligosaccharid
novel
glycan
cap
project
mucinlik
domain
togeth
probabl
restrict
access
conserv
receptorbind
site
rb
sequest
insid
chalic
bowl
articl
focu
zebov
structur
role
viral
attach
membran
fusion
crystal
zebov
gp
challeng
owe
intrins
flexibl
extens
nand
olink
glycosyl
oligomer
molecul
order
promot
crystal
mucinlik
domain
transmembran
domain
excis
two
nlink
glycosyl
site
posit
elimin
gp
complex
antibodi
recogn
conform
gp
gp
contain
epitop
nearli
complet
zebov
gp
figur
form
trimer
solut
fulli
capabl
mediat
viru
entri
transmembran
domain
restor
crystal
structur
illustr
prefus
form
threelob
chalic
shape
bowl
chalic
assembl
three
gp
subunit
figur
base
chalic
form
three
gp
subunit
cradl
encircl
gp
trimer
figur
gp
subunit
respons
cellular
attach
contain
put
receptorbind
region
well
heavili
glycosyl
region
term
mucinlik
domain
gp
separ
three
subdomain
base
head
glycan
cap
gp
base
subdomain
contain
four
discontinu
section
residu
form
hydrophob
semicircular
surfac
interact
intern
fusion
loop
heptad
repeat
region
gp
figur
gp
base
form
clamp
probabl
stabil
gp
prefus
conform
thu
prevent
spring
prematur
also
within
gp
base
form
intermolecular
disulfid
bond
gp
subunit
resid
loop
proxim
viral
membran
end
gp
base
subunit
unexpectedli
electron
densiti
visibl
side
chain
entir
region
contain
counterpart
gp
cystein
suggest
region
mobil
gp
head
central
subdomain
locat
base
glycan
cap
compos
residu
four
discontinu
section
residu
signific
portion
subdomain
like
expos
solvent
within
bowl
chalic
thought
contain
residu
requir
receptor
bind
gp
glycan
cap
compos
continu
polypeptid
chain
residu
form
gp
head
subdomain
subdomain
fulli
expos
outer
surfac
involv
contact
trimer
interfac
within
gp
glycan
cap
cluster
least
four
predict
nlink
oligosaccharid
link
ctermin
glycan
cap
approxim
gp
mucinlik
domain
domain
predict
contain
low
secondari
structur
complex
heavili
glycosyl
approxim
four
nand
approxim
olink
oligosaccharid
crystal
zebov
gp
requir
mucinlik
domain
excis
order
improv
chemic
conform
homogen
sampl
least
one
protect
antibodi
epitop
contain
within
visual
gp
subunit
respons
fusion
viral
host
cell
membran
contain
hydrophob
intern
fusion
loop
two
heptad
repeat
cx
cc
disulfid
bond
motif
membraneproxim
extern
region
transmembran
anchor
intern
fusion
loop
residu
display
seri
hydrophob
residu
bound
antiparallel
disulfidelink
figur
prefus
state
intern
fusion
loop
wrap
around
outsid
gp
trimer
hydrophob
side
chain
sequest
solvent
pack
neighbor
gp
monom
interestingli
although
ebov
gp
classifi
class
intern
fusion
loop
structur
quit
differ
class
viral
gp
exampl
fusion
sequenc
influenza
viru
hemagglutinin
ha
parainfluenza
viru
f
form
helic
resid
free
nterminu
gp
releas
enzymat
cleavag
instead
fusion
loop
ebov
close
resembl
structur
fusion
loop
class
ii
iii
gp
flaviviru
e
vesicular
stomat
viru
protein
g
gb
figur
first
heptad
repeat
order
zebov
gp
crystal
structur
region
structur
divid
four
segment
b
c
first
two
segment
b
residu
form
approxim
kink
delin
b
unusu
stutter
rather
normal
period
heptad
repeat
occur
within
bend
b
stutter
suggest
act
conform
switch
also
observ
parainfluenza
viru
f
c
residu
form
extend
coil
linker
b
segment
residu
form
amphipath
helix
hydrophob
face
three
helic
trimer
pack
togeth
form
interfac
peplom
mixtur
complex
oligomannos
hybridtyp
glycan
found
intact
mucinlik
domain
contain
zebov
gp
glycan
main
structur
outsid
mucinlik
domain
like
complextyp
natur
mucindelet
zebov
gp
sensit
deglycosyl
peptid
nglycosidas
f
endoglycosidas
h
molecular
model
biantennari
complextyp
nlink
glycan
zebov
gp
structur
reveal
thick
coat
oligosaccharid
surfac
gp
figur
coat
extend
across
intact
gp
mucinlik
domain
contain
approxim
addit
oligosaccharid
chain
across
approxim
residu
glycocalyx
surround
zebov
probabl
form
shield
protect
humor
immun
respons
andor
confer
stabil
insid
outsid
host
inde
antibodi
rais
natur
infect
direct
toward
sgp
even
though
zebov
gp
thick
coat
oligosaccharid
region
vulner
locat
base
gp
chalic
cathepsincleavag
site
within
mucinlik
domain
importantli
sever
monoclon
antibodi
isol
character
neutral
vitro
protect
rodent
model
epitop
antiebovneutr
antibodi
determin
xray
crystallographi
neutral
escap
studi
andor
linear
peptid
dot
blot
detail
review
see
extens
character
antiebovneutr
antibodi
monoclon
antibodi
deriv
bone
marrow
rna
donat
human
survivor
kikwit
zair
democrat
republ
congo
outbreak
found
neutral
zebov
vitro
offer
protect
lethal
zebov
challeng
rodent
model
howev
passiv
transfer
antibodi
nonhuman
primat
unabl
induc
steril
immun
crystal
structur
ebov
complex
fab
illustr
antibodi
bind
vulner
nonglycosyl
site
base
gp
chalic
specif
bridg
three
discontinu
region
gp
gp
gp
residu
gp
residu
ntermin
region
releas
furin
cleavag
gp
residu
base
intern
fusion
loop
gp
sequenc
involv
contact
poorli
conserv
variou
ebov
speci
thu
explain
specif
zebov
speci
requir
gp
gp
recognit
crystal
structur
reveal
contact
gp
made
fairli
weak
van
der
waalstyp
interact
main
chain
nitrogen
side
chain
carbon
note
posit
threonin
mutat
valin
elimin
nlink
glycosyl
site
improv
sampl
homogen
instead
major
interact
made
gp
requir
gp
rel
strong
contact
gp
suggest
role
gp
epitop
primarili
stabil
prefus
conform
gp
recognit
inde
recogn
ebov
gp
gp
gp
disulfid
bond
reduc
recogn
postfus
gp
sixhelix
bundl
first
antivir
antibodi
shown
bridg
receptorbind
fusion
subunit
viral
gp
recent
howev
two
broadli
neutral
antiinfluenza
viru
hemagglutinin
antibodi
identifi
also
bridg
ha
ha
neutral
block
conform
chang
associ
fusion
anoth
monoclon
antibodi
term
recogn
residu
locat
base
gp
chalic
residu
identifi
neutral
escap
experi
lie
near
epitop
intrigu
specul
whether
base
gp
chalic
repres
potenti
sweet
spot
neutral
review
passiv
transfer
neutral
antibodi
offer
protect
challeng
number
acut
virus
ebov
infect
abil
neutral
antibodi
serv
passiv
immunotherapeut
well
understood
zebov
outbreak
kikwit
convalesc
sera
five
donor
transfus
eight
patient
day
postinfect
eight
treat
patient
one
succumb
diseas
suggest
convalesc
sera
could
use
treatment
patient
recov
ebov
control
experi
antibodi
given
closer
time
exposur
passiv
transfer
convalesc
sera
monoclon
antibodi
shown
protect
rodent
nonhuman
primat
ebov
challeng
may
also
improv
surviv
rate
laboratori
worker
accident
expos
ebov
studi
cite
evid
use
antiebovneutr
antibodi
potenti
passiv
immunotherapeut
treatment
howev
recent
studi
cast
doubt
feasibl
neutral
antibodi
effect
protect
human
ebov
infect
possibl
sinc
singl
ebov
particl
lethal
dose
primat
may
difficult
singl
monoclon
antibodi
provid
steril
clearanc
perhap
cocktail
monoclon
antibodi
sever
uniqu
epitop
might
confer
improv
protect
import
identifi
multipl
uniqu
antibodi
epitop
ebov
gp
could
combin
antibodi
cocktail
includ
addit
ebov
envelop
gp
directli
mediat
bind
virion
host
cell
number
cellular
factor
includ
dcsignlsign
lsectin
hmgl
famili
receptor
implic
attach
factor
howev
none
protein
individu
necessari
suffici
viral
entri
henc
critic
cellsurfac
receptor
respons
ebov
attach
yet
identifi
despit
signific
effort
appear
ebov
enter
receptormedi
endocytot
mechan
still
unclear
whether
clathrin
caveolaeor
cholesteroldepend
process
use
recombin
system
use
pseudotyp
retroviru
particl
zebov
gp
live
viru
studi
use
chemic
inhibitor
clathrinand
caveolaemedi
endocytosi
point
use
caveola
clathrin
ebov
entri
howev
cell
lack
caveola
still
infect
ebov
previou
structureblind
studi
initi
local
receptorbind
region
residu
approxim
residu
ntermin
region
form
base
head
subdomain
gp
extend
bottom
nearli
top
chalic
extens
mutat
analysi
gp
perform
sever
group
identifi
least
residu
gp
import
infect
residu
mutat
result
secret
analyz
protein
yet
infect
abrog
map
residu
onto
zebov
structur
allow
assign
probabl
function
figur
among
residu
resid
gp
base
subdomain
near
gp
gp
disulfid
bond
like
import
fusionmedi
conform
chang
rather
receptor
bind
residu
buri
core
gp
probabl
play
role
structur
stabil
residu
pack
hydrophob
residu
neighbor
intern
fusion
loop
mutat
residu
may
affect
structur
integr
fusion
loop
gp
trimer
remain
six
residu
resid
close
gp
surfac
cluster
togeth
approxim
site
insid
concav
bowl
may
rb
ebov
three
lysin
set
six
residu
recent
confirm
like
cellcontact
site
inspect
crystal
structur
suggest
surround
residu
may
also
involv
receptor
bind
crystal
structur
illustr
put
rb
recess
bowl
chalic
possibl
mask
heavili
glycosyl
mucinlik
domain
gp
glycan
cap
predict
site
may
becom
expos
better
expos
entri
endosom
cathepsin
cleavag
occur
cathepsin
l
trim
ebov
gp
origin
kda
size
initi
fragment
follow
cleavag
approxim
speci
gp
remain
link
gp
figur
digest
catl
yield
approxim
fragment
gp
function
entri
gp
may
digest
catb
endosom
peptides
fragment
crystal
structur
indic
probabl
site
cathepsin
cleavag
loop
reach
residu
disord
gp
structur
solventexpos
mobil
perhap
flexibl
natur
loop
render
attract
access
proteas
cleavag
inde
separ
simultan
biochem
studi
confirm
loop
residu
site
cathepsin
cleavag
cleavag
would
remov
glycan
cap
mucinlik
region
gp
yield
approxim
gp
core
encircl
gp
rb
gp
complet
expos
addit
cathepsin
cleavag
may
expos
set
amino
acid
residu
resid
convex
surfac
underneath
glycan
cap
catb
andor
catl
cleavag
gp
shown
increas
bind
infect
target
cell
genet
remov
mucinlik
domain
result
cell
bind
similar
observ
catltreat
gp
taken
togeth
data
suggest
cleavag
catl
facilit
interact
entri
factor
block
glycan
cap
mucinlik
domain
prior
cleavag
interestingli
catl
also
recent
shown
process
gp
nipah
hendra
virus
well
sar
coronaviru
hypothes
initi
attach
ebov
target
cell
probabl
occur
via
lectin
perhap
also
lowaffin
lowfrequ
interact
put
rb
figur
higher
affin
facilit
bind
receptor
could
occur
endosom
cathepsin
proteolyt
cleavag
gp
exposur
rb
figur
similar
exampl
might
two
attach
protein
gb
gc
form
initi
lowaffin
interact
cellsurfac
heparan
sulfat
proteoglycan
follow
specif
proteinprotein
interact
gd
cell
surfac
lead
entri
fusion
review
fusion
viral
host
cell
membran
high
energet
barrier
catalyz
fusion
reaction
viral
fusion
protein
undergo
larg
protein
conform
chang
use
releas
free
energi
lower
activ
barrier
gener
step
class
gpmediat
viral
host
cell
membran
fusion
fairli
well
understood
work
influenza
viru
ha
parainfluenza
viru
f
other
see
review
base
work
structur
zebov
follow
mechan
membran
fusion
propos
figur
first
step
viralhost
cell
membran
fusion
requir
prime
envelop
gp
metast
conform
subsequ
activ
fusion
mani
virus
influenza
viru
ha
requir
gp
endoproteolyt
cleav
furin
case
influenza
viru
ha
furin
cleavag
unlock
constraint
fusion
peptid
prime
gp
subsequ
sprung
endosom
low
ph
stark
contrast
zebov
gp
requir
furin
cleavag
viral
infect
number
cell
line
nonhuman
primat
base
crystal
structur
ebov
hydrophob
fusion
residu
display
loop
within
disulfidebond
antiparallel
conform
restrict
lack
free
nterminu
gp
subunit
moreov
mucinlik
domain
predict
low
secondari
structur
complex
ntermin
intern
fusion
loop
specul
flexibl
domain
may
provid
addit
conform
freedom
intern
fusion
loop
absenc
furin
cleavag
fusion
process
next
step
requir
trigger
metast
prefus
conform
gp
fusion
mani
virus
influenza
flavivirus
low
ph
trigger
gp
like
conform
chang
necessari
membran
fusion
key
histidin
residu
becom
proton
acid
environ
endosom
histidin
locat
vicin
posit
charg
residu
prefus
conform
proton
rearrang
instead
form
electrostat
interact
neg
charg
residu
postfus
conform
virus
coreceptorbind
trigger
conform
rearrang
virus
avian
leukosi
virusa
receptor
bind
low
ph
requir
fusogen
trigger
zebov
gp
well
defin
low
ph
endosom
necessari
gpmediat
cellcel
fusion
infect
zebov
gppseudotyp
vesicular
stomat
indiana
viru
howev
low
ph
depend
probabl
directli
involv
trigger
zebov
gp
gp
interfac
primarili
nonpolar
hydrophob
lack
array
histidin
andor
acid
residu
commonli
associ
phdepend
conform
chang
viral
gp
furthermor
prefus
conformationspecif
monoclon
antibodi
bind
zebov
ph
suggest
low
ph
alon
trigger
gp
instead
requir
low
ph
like
activ
endosom
cathepsin
proteolyz
gp
unclear
whether
cathepsin
cleavag
zebov
gp
caus
initi
conform
chang
trigger
fusogen
conform
altern
cathepsin
cleavag
activ
gp
trigger
addit
yet
undiscov
cellular
factor
figur
c
although
ident
trigger
unknown
structur
clear
gp
clamp
stabil
gp
must
releas
allow
rearrang
permit
fusion
comparison
prefus
zebov
postfus
zebov
gp
fragment
structur
illustr
four
segment
ad
must
unwind
prefus
ring
around
gp
straighten
assembl
singl
helic
rod
figur
process
rotat
translat
movement
b
posit
intern
fusion
loop
top
trimer
gp
hydrophob
residu
display
intern
fusion
loop
abl
penetr
host
membran
adopt
helic
charact
describ
nuclear
magnet
reson
studi
free
fusion
peptid
sodium
dodecyl
sulfat
micel
detergentresist
membran
fraction
hypothes
conserv
fusionloop
import
induc
bilay
destabil
elong
gp
structur
result
fusion
loop
penetr
target
membran
also
call
prehairpin
intermedi
prehairpin
intermedi
conform
halflif
rang
minut
virus
conform
may
last
second
format
prehairpin
intermedi
zebov
gp
collaps
foldedback
conform
gp
may
flex
elbowlik
cx
cc
hing
allow
approach
trimer
bundl
figur
collaps
prehairpin
intermedi
distort
viral
hostcel
bilay
draw
two
bilay
close
one
anoth
merg
hemifus
stalk
ultim
open
fusion
pore
figur
ebov
gp
one
studi
protein
ebov
owe
critic
role
viral
entri
potenti
target
therapeut
although
crystal
structur
zebov
gp
shed
light
mani
role
mani
question
remain
unansw
ident
ebov
host
receptor
receptor
necessari
suffici
ebov
entri
still
elud
research
hypothes
cathepsin
cleavag
zebov
probabl
leav
behind
convex
surfac
bind
critic
entri
factor
fold
locat
physiochem
properti
site
provid
new
lead
search
ebov
receptor
rb
conserv
within
filoviru
famili
sequenc
align
reveal
ebov
residu
involv
entri
well
conserv
among
zebov
sudan
divoir
rebov
speci
henc
zebov
structur
make
repres
model
use
design
entri
inhibitor
immunotherapeut
speci
ebov
howev
although
previou
studi
use
gp
fragment
suggest
ebov
marv
compet
bind
receptor
sequenc
residu
involv
entri
well
conserv
ebov
marv
perhap
marv
bind
differ
receptor
bind
receptor
differ
way
use
differ
amino
acid
residu
perhap
receptor
bind
main
chain
framework
share
ebov
marv
note
marv
enter
cell
independ
catb
henc
structur
differ
must
occur
trigger
gp
conform
chang
unclear
whether
precis
role
cathepsin
cleavag
prime
gp
conform
chang
open
rb
similar
differ
ssgp
sgp
gp
first
amino
acid
sequenc
ident
three
gp
differ
ctermini
oligomer
state
preferenti
reactiv
survivor
sera
addit
gp
embed
viral
surfac
sgp
ssgp
secret
abundantli
yet
unclear
share
sequenc
adopt
fold
differ
three
gp
variant
differenti
antibodi
reactiv
result
fold
packag
altern
quaternari
scaffold
howev
vaccin
develop
immunogen
must
design
elicit
neutral
antibodi
viral
particl
rather
secret
shed
protein
zair
prefus
trimer
adopt
bowllik
chalic
shape
three
glycoprotein
gp
subunit
form
bowl
chalic
three
gp
subunit
wrap
around
base
chalic
form
cradl
gp
consist
three
subdomain
base
head
glycan
cap
hydrophob
residu
gp
intern
fusion
loop
display
heptad
repeat
region
hr
separ
four
segment
b
c
zair
ebolavirusgp
act
clamp
gp
four
discontinu
stretch
gp
fold
togeth
form
hydrophob
surfac
term
gp
base
subdomain
gp
base
subdomain
form
clamp
gp
prefus
conform
probabl
prevent
prematur
spring
fusogen
state
model
biantennari
complextyp
oligosaccharid
zair
ebolaviru
zebov
reveal
surfac
cloak
thick
coat
nlink
glycan
extens
glycosyl
glycan
cap
mucinlik
domain
probabl
protect
viru
immun
surveil
thu
explain
neutral
antibodi
elicit
natur
infect
critic
zebov
host
receptor
unknown
structur
mutat
studi
identifi
patch
lysin
resid
surfac
subsequ
mutagenesi
experi
reveal
lysin
import
viral
attach
three
distinct
put
receptorbind
site
exist
trimer
buri
insid
bowl
chalic
proteolyt
cleavag
zebov
gp
cathepsin
b
andor
l
requir
viral
entri
cathepsin
b
andor
l
cleav
zebov
gp
approxim
subunit
fragment
thu
remov
mucinlik
domain
glycan
cap
suggest
cleavag
cathepsin
better
expos
patch
lysin
zebov
gp
may
expos
addit
residu
surfac
improv
interact
entri
factor
otherwis
block
mucinlik
domain
glycan
cap
viral
host
cell
membran
fusion
mediat
gp
analog
class
viral
fusion
protein
influenza
viru
ha
trigger
releas
gp
constraint
gp
unknown
remov
gp
constraint
allow
gp
form
singl
helix
posit
intern
fusion
loop
top
gp
insert
host
membran
prehairpin
intermedi
extend
prehairpin
intermedi
fold
back
distort
viral
hostcel
bilay
facilit
format
hemifus
stalk
format
low
energi
sixhelix
bundl
juxtapos
intern
fusion
loop
transmembran
domain
facilit
format
fusion
pore
final
merger
host
viral
membran
primari
open
read
frame
ebolaviru
gp
encod
sgp
shown
white
red
rectangl
proteolyt
cleavag
presgp
furin
result
format
matur
sgp
small
nonstructur
fragment
term
cotranscript
stutter
gp
gene
result
two
addit
glycoprotein
gp
ssgp
gp
virionattach
glycoprotein
proteolyt
cleavag
precursor
pregp
furin
result
two
subunit
gp
gp
remain
link
disulfid
bond
gp
gp
heterodim
trimer
form
viral
surfac
peplom
enzym
also
cleav
envelop
gp
site
proxim
gp
transmembran
domain
therebi
releas
solubl
trimer
gp
ssgp
small
secret
glycoprotein
share
first
amino
acid
sgp
gp
differ
cterminu
two
nonshar
residu
color
yellow
report
ssgp
form
monom
solut
gp
glycoprotein
sgp
secret
glycoprotein
ssgp
small
secret
glycoprotein
tace
enzym
tm
transmembran
anchor
